Opko Health reported $3.08M in Interest Expense on Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Abbott ABT:US USD 86M 46M
ALKERMES ALKS:US USD 3.55M 1.18M
Alnylam Pharmaceuticals ALNY:US USD 41.08M 1.52M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 299M 14M
Esperion Therapeutics ESPR:US USD 14.15M 113K
Exact Sciences EXAS:US USD 5.24M 724K
Halozyme Therapeutics HALO:US USD 7.51M 4.41M
Insmed INSM:US USD 3.35M 4K
Intercept Pharmaceuticals ICPT:US USD 5.24M 1.43M
IONIS PHARMACEUT IONS:US USD 2.14M 9K
Ironwood Pharmaceuticals IRWD:US USD 1.52M 683K
Laboratory Of America LH:US USD 46.3M 3.8M
Moderna Inc MRNA:US USD 8M 3M
Myriad Genetics MYGN:US USD 800K 200K
Neurocrine Biosciences NBIX:US USD 1.2M 1000K
Ptc Therapeutics PTCT:US USD 19.48M 2.8M
Quest Diagnostics DGX:US USD 37M 1000K
Sarepta Therapeutics SRPT:US USD 14.74M 1.29M
Teva Pharmaceutical Industries TEVA:US USD 230M 5M
United Therapeutics UTHR:US USD 9.2M 3M